Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. USPH
USPH logo

USPH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
75.830
Open
75.090
VWAP
75.07
Vol
63.32K
Mkt Cap
1.13B
Low
74.010
Amount
4.75M
EV/EBITDA(TTM)
14.65
Total Shares
15.12M
EV
1.55B
EV/OCF(TTM)
20.65
P/S(TTM)
1.45
U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 780 outpatient physical therapy clinics in 44 states. The Company’s reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. Physical Therapy Operations segment consist of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. IIP segment includes onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.
Show More

Events Timeline

(ET)
2026-02-25
18:40:00
Company Reports Q4 Revenue of $202.73M, Beating Expectations
select
2026-02-25
18:40:00
U.S. Physical Therapy Sees 2026 Adjusted EBITDA of $102.0M-$106.0M
select
2026-02-02 (ET)
2026-02-02
16:10:00
U.S. Physical Therapy Acquires Industrial Injury Prevention Business for $15.1 Million
select
2026-02-02
07:40:00
U.S. Physical Therapy Forms 10-Year Alliance with NYU Langone Health
select
2026-01-05 (ET)
2026-01-05
07:40:00
U.S. Physical Therapy Acquires Management Services Company with $8M Annual Revenue
select
2025-11-05 (ET)
2025-11-05
17:16:16
U.S. Physical Therapy announces Q3 operating EPS of 66 cents, matching expectations.
select

News

Newsfilter
1.0
03-12Newsfilter
U.S. Physical Therapy Presents at Barclays Healthcare Conference
  • Company Overview: Founded in 1990, U.S. Physical Therapy operates 783 outpatient clinics across 44 states, providing a wide range of orthopedic and sports injury care, demonstrating its extensive reach and influence in the industry.
  • Service Range: In addition to treating neurologically-related injuries and rehabilitating injured workers, USPH's industrial injury prevention services enhance employee performance and safety, thereby strengthening the company's competitive position in the market.
  • Executive Presentation: CEO Chris Reading presented at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026, showcasing the company's strategic positioning and future direction in the healthcare sector, which bolsters investor confidence.
  • Industry Outlook: With increasing demand for physical therapy, USPH's business model and service offerings are poised to capture a larger share of the rapidly growing healthcare market, particularly as ongoing innovations in prevention and rehabilitation drive future growth.
Fool
6.5
03-04Fool
4D Advisors Fully Exits U.S. Physical Therapy Stake
  • Complete Exit: 4D Advisors disclosed in a SEC filing that it fully exited its stake in U.S. Physical Therapy by selling 110,000 shares in Q4 2026, resulting in a $9.34 million decline in position value, indicating a loss of investor confidence in the stock.
  • Flat Stock Performance: As of February 17, 2026, U.S. Physical Therapy shares were priced at $86.54, reflecting only a 0.2% increase over the past year, which, in the context of a rising broader market, suggests relative underperformance that may prompt investors to reassess their opportunity costs.
  • Lackluster Financial Growth: The latest earnings report showed revenue growth of over 16% to approximately $173.8 million; however, concerns over declining year-over-year profitability led to a 12% drop in shares, highlighting market apprehension regarding future earnings potential.
  • Strategic Shift Indication: The complete exit by 4D Advisors signals that the investment no longer met return hurdles, particularly amid increased stock volatility, while CEO Chris Reading pointed to potential long-term value from acquisitions and new hospital relationships, although short-term stock performance remains under pressure.
Yahoo Finance
9.5
03-04Yahoo Finance
Quarterly Review of U.S. Outpatient & Specialty Care Industry
  • Industry Performance Overview: In the outpatient and specialty care sector, the seven tracked stocks reported Q4 revenues exceeding analysts' expectations by 2.5%, indicating the industry's stability and attractiveness amid rising healthcare costs.
  • U.S. Physical Therapy Growth: U.S. Physical Therapy reported revenues of $202.7 million, a 12.3% year-over-year increase that surpassed analysts' expectations by 1.7%, reflecting progress in key initiatives, although EPS was in line with forecasts.
  • DaVita Strong Performance: DaVita's revenue reached $3.62 billion, up 9.9% year-over-year, exceeding analysts' expectations by 3.2%, with its stock rising 36.7% since reporting, showcasing market confidence in its robust performance.
  • Surgery Partners Ongoing Challenges: Surgery Partners reported revenues of $885 million, a 2.4% year-over-year increase that exceeded expectations by 1.9%, but its full-year revenue and EBITDA guidance significantly missed analysts' forecasts, resulting in a 13.3% drop in stock price.
seekingalpha
9.5
02-26seekingalpha
U.S. Physical Therapy, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook
  • Strong Financial Performance: For the year ending 2025, adjusted EBITDA increased by $13.2 million, a 16.2% improvement, and net revenue rose by 16.3%, demonstrating significant financial progress despite ongoing Medicare rate reductions.
  • Acquisitions and Strategic Partnerships: The company has made several acquisitions in the Pacific Northwest and New York City, with hospital partnerships expected to contribute at least $14 million to EBITDA by 2027, further strengthening its market position.
  • 2026 Outlook: Management expects adjusted EBITDA for 2026 to be in the range of $102 million to $106 million, including $2.5 million from Medicare revenue increases, reflecting confidence in future growth.
  • Operational Efficiency Gains: Average visits per clinic per day reached 32.7 in Q4, a record high for the company, with total patient visits growing 11.2% year-over-year, indicating significant improvements in customer service and operational efficiency.
NASDAQ.COM
2.0
02-26NASDAQ.COM
US Physical Therapy (USPH) Earnings Transcript
NASDAQ.COM
2.0
02-26NASDAQ.COM
U.S. Physical Therapy Stock Oversold Analysis
  • Oversold Status: U.S. Physical Therapy, Inc. (USPH) has an RSI of 27.8, indicating it has entered oversold territory below the 30 threshold, suggesting that recent selling pressure may be exhausting, thus presenting potential buying opportunities for investors.
  • Dividend Yield: The company's recent annualized dividend of $1.84 per share translates to an annual yield of 2.25% based on the current share price of $81.68, making it attractive for dividend-seeking investors.
  • Market Comparison: Compared to the average RSI of 54.2 for dividend stocks covered by Dividend Channel, USPH's significantly lower RSI indicates that its stock price may be undervalued, potentially drawing more investor interest.
  • Investor Strategy: While dividends are not always predictable, examining USPH's dividend history can assist investors in assessing the likelihood of continued dividend payments, enabling more informed investment decisions.
Wall Street analysts forecast USPH stock price to rise
4 Analyst Rating
Wall Street analysts forecast USPH stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
100.00
Averages
101.50
High
103.00
Current: 0.000
sliders
Low
100.00
Averages
101.50
High
103.00
Jefferies
Buy
downgrade
$110 -> $102
AI Analysis
2026-03-09
Reason
Jefferies
Price Target
$110 -> $102
AI Analysis
2026-03-09
downgrade
Buy
Reason
Jefferies assumed coverage of U.S. Physical Therapy with a Buy rating and a price target of $102, down from $110. As the company pursues strategic hospital alliances and faces a more favorable pricing environment with improved Medicare rates, the firm sees organic growth acceleration and margin expansion, the analyst tells investors.
JPMorgan
Benjamin Rossi
Overweight
downgrade
$110 -> $100
2025-11-24
Reason
JPMorgan
Benjamin Rossi
Price Target
$110 -> $100
2025-11-24
downgrade
Overweight
Reason
JPMorgan analyst Benjamin Rossi lowered the firm's price target on U.S. Physical Therapy to $100 from $110 and keeps an Overweight rating on the shares. The firm updated the company's model post the Q3 report.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for USPH
Unlock Now

Valuation Metrics

The current forward P/E ratio for US Physical Therapy Inc (USPH.N) is 27.95, compared to its 5-year average forward P/E of 34.48. For a more detailed relative valuation and DCF analysis to assess US Physical Therapy Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
34.48
Current PE
27.95
Overvalued PE
39.27
Undervalued PE
29.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
20.51
Current EV/EBITDA
17.19
Overvalued EV/EBITDA
23.00
Undervalued EV/EBITDA
18.02

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.17
Current PS
1.47
Overvalued PS
2.63
Undervalued PS
1.71

Financials

AI Analysis
Annual
Quarterly

Whales Holding USPH

C
Copeland Capital Management, LLC
Holding
USPH
+6.51%
3M Return
V
Virtus Investment Advisers, LLC
Holding
USPH
+1.92%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is US Physical Therapy Inc (USPH) stock price today?

The current price of USPH is 75.355 USD — it has increased 0.88

What is US Physical Therapy Inc (USPH)'s business?

U.S. Physical Therapy, Inc. is an operator of outpatient physical therapy clinics and provider of industrial injury prevention services. It owns and/or manages 780 outpatient physical therapy clinics in 44 states. The Company’s reportable segments include the Physical Therapy Operations segment and the Industrial Injury Prevention Services (IIP) segment. Physical Therapy Operations segment consist of physical therapy, speech therapy and occupational therapy clinics and home-care physical and speech therapy practices that provide pre- and post-operative care and treatment for a variety of orthopedic-related disorders, sports-related injuries, and rehabilitation of injured workers. IIP segment includes onsite services for clients’ employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations and ergonomic assessments. The majority of these services are contracted with and paid for directly by employers.

What is the price predicton of USPH Stock?

Wall Street analysts forecast USPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for USPH is101.50 USD with a low forecast of 100.00 USD and a high forecast of 103.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is US Physical Therapy Inc (USPH)'s revenue for the last quarter?

US Physical Therapy Inc revenue for the last quarter amounts to 202.73M USD, increased 12.35

What is US Physical Therapy Inc (USPH)'s earnings per share (EPS) for the last quarter?

US Physical Therapy Inc. EPS for the last quarter amounts to -0.43 USD, decreased -182.69

How many employees does US Physical Therapy Inc (USPH). have?

US Physical Therapy Inc (USPH) has 4200 emplpoyees as of March 25 2026.

What is US Physical Therapy Inc (USPH) market cap?

Today USPH has the market capitalization of 1.13B USD.